The essential elements of Alzheimer's disease.

The Journal of Biological Chemistry
Peng LeiAshley I Bush

Abstract

Treatments for Alzheimer's disease (AD) directed against the prominent amyloid plaque neuropathology are yet to be proved effective despite many phase 3 clinical trials. There are several other neurochemical abnormalities that occur in the AD brain that warrant renewed emphasis as potential therapeutic targets for this disease. Among those are the elementomic signatures of iron, copper, zinc, and selenium. Here, we review these essential elements of AD for their broad potential to contribute to Alzheimer's pathophysiology, and we also highlight more recent attempts to translate these findings into therapeutics. A reinspection of large bodies of discovery in the AD field, such as this, may inspire new thinking about pathogenesis and therapeutic targets.

References

Jun 1, 1991·Lancet·D R Crapper McLachlanD F Andrews
Oct 1, 1991·Trends in Pharmacological Sciences·J Hardy, D Allsop
Jun 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·J G WoodL I Binder
Jul 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·I Grundke-IqbalL I Binder
Jun 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·C L MastersK Beyreuther
Aug 16, 1984·Biochemical and Biophysical Research Communications·G G Glenner, C W Wong
Apr 19, 1984·Nature·G A HowellC J Frederickson
Jul 1, 1981·Journal of Neuropathology and Experimental Neurology·D W Vaughan, A Peters
Nov 13, 1995·Biochemical and Biophysical Research Communications·D Schubert, M Chevion
Aug 1, 1995·Journal of Neurochemistry·D A LoefflerP A LeWitt
Jan 1, 1995·Journal of Neurochemistry·S BodovitzW L Klein
Apr 1, 1994·Biological Psychiatry·G BartzokisS R Marder
Sep 10, 1993·Neuroreport·S J van RensburgJ J Taljaard
Jul 1, 1995·Neurobiology of Aging·M D LedesmaI Correas
Oct 1, 1996·Journal of Neurophysiology·P Q Trombley, G M Shepherd
Nov 1, 1996·The European Journal of Neuroscience·V VlachováL Vyklický
Dec 10, 1996·Proceedings of the National Academy of Sciences of the United States of America·R D PalmiterS D Findley
Sep 2, 1997·Proceedings of the National Academy of Sciences of the United States of America·M A SmithG Perry
Oct 23, 1997·The Journal of Biological Chemistry·X HuangA I Bush
Jul 17, 1998·Journal of the Neurological Sciences·M A LovellW R Markesbery
Mar 31, 1999·Proceedings of the National Academy of Sciences of the United States of America·S LammichF Fahrenholz
Aug 7, 1999·The Journal of Biological Chemistry·R A ChernyA I Bush
Apr 1, 2000·Current Opinion in Chemical Biology·A I Bush
Jun 13, 2000·Alzheimer Disease and Associated Disorders·M Takahashi, S H Snyder
Feb 22, 2001·Free Radical Biology & Medicine·C A RottkampM A Smith
Mar 14, 2001·Brain Research·W H YuP E Fraser
Sep 27, 2001·Proceedings of the National Academy of Sciences of the United States of America·D E Barañano, S H Snyder

❮ Previous
Next ❯

Citations

Feb 23, 2021·The Journal of Biological Chemistry·Jeung-Hoi HaStewart N Loh
Mar 2, 2021·Journal of Alzheimer's Disease : JAD·Guimei ZhangLi Sun
May 6, 2021·Biomedicines·Hilary Y LiuElias Aizenman
Sep 2, 2021·Translational Neurodegeneration·Heather M Wilkins, Russell H Swerdlow

❮ Previous
Next ❯

Software Mentioned

CuATSM
QSM
BioFinder

Related Concepts

Related Feeds

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

Related Papers

Journal of Alzheimer's Disease : JAD
Patricia L FernándezK S Rao
Brain Research Bulletin
B S Shastry, F J Giblin
Progress in Molecular Biology and Translational Science
Goran ŠimićPatrick R Hof
© 2021 Meta ULC. All rights reserved